We are live on ! Find out more
PHVS icon

Pharvaris

20 hedge funds and large institutions have $494M invested in Pharvaris in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $397M → $494M (+$96.9M)

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

1.98% more ownership

Funds ownership: 65.46%67.43% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

9% less funds holding

Funds holding: 2220 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.34%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
1
Increased
7
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$73.3M
FCMI
2
Foresite Capital Management IV
California
$71.8M -$280K -15,000 -0.5%
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$70.3M
Viking Global Investors
4
Viking Global Investors
Connecticut
$55.1M +$216K +11,604 +0.5%
GA
5
General Atlantic
New York
$53.5M
VP
6
venBio Partners
California
$50.9M -$34.6K -1,859 -0.1%
DM
7
Deerfield Management
New York
$26.3M -$7.21M -386,735 -25%
CAM
8
Cormorant Asset Management
Massachusetts
$25.3M +$8.59M +461,065 +67%
SCM
9
Suvretta Capital Management
New York
$18.3M
5VM
10
5AM Venture Management
California
$13M +$11M +587,600 New
NHAS
11
Novo Holdings A/S
Denmark
$11.5M +$56.2K +3,018 +0.6%
PAMS
12
Pictet Asset Management (Switzerland)
Switzerland
$10.2M -$1.4M -75,000 -14%
EAM
13
Eventide Asset Management
Massachusetts
$9.95M +$2.75M +147,632 +49%
Millennium Management
14
Millennium Management
New York
$1.81M -$493K -26,432 -24%
Goldman Sachs
15
Goldman Sachs
New York
$1.26M +$20.8K +1,115 +2%
FCMV
16
Foresite Capital Management V
California
$755K
Geode Capital Management
17
Geode Capital Management
Massachusetts
$412K
Morgan Stanley
18
Morgan Stanley
New York
$372K +$11.8K +631 +4%
Bank of America
19
Bank of America
North Carolina
$91K -$30.5K -1,639 -28%
UBS Group
20
UBS Group
Switzerland
$18K +$1.32K +71 +10%
DCM
21
DAFNA Capital Management
California
-$628K -34,615 Closed
JP Morgan Chase
22
JP Morgan Chase
New York
-$64K -3,429 Closed
TRCT
23
Tower Research Capital (TRC)
New York
-$1K -77 Closed

PHVS Hedge Fund Activity: Q2 2022 in Review

20 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q2 2022, worth a combined $494M — up 24% from $397M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PHVS and 1 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 7 added.

The largest buyer was 5AM Venture Management, opening a new position worth an estimated $11M. The largest seller was Deerfield Management, cutting an estimated $7.21M.

  • 20 institutional investors held Pharvaris (PHVS) as of Q2 2022, down from 22 in Q1 2022.
  • Funds reported $494M of Pharvaris stock for Q2 2022, up 24% quarter-over-quarter.
  • 1 fund opened new Pharvaris positions in Q2 2022 and 3 closed out, a net change of -2 holders.
  • The largest Pharvaris buyer in Q2 2022 was 5AM Venture Management, an estimated $11M added.
  • The largest Pharvaris seller in Q2 2022 was Deerfield Management, an estimated $7.21M sold.

Based on aggregated 13F filings for Q2 2022.